Hidoc Dr | Medical Learning App for Doctors

Today's Updates

Phase 2 ACUITY Analysis Shows Privosegtor Associated With Smaller Early NfL and GFAP Increases in Acute Optic Neuritis Isabella Ciccone, MPH

Published Date: 29 Oct 2026

New biomarker data showed smaller post-onset increases in plasma neurofilament light chain and glial fibrillary acidic protein with privosegtor added to steroids in patients with acute optic neuritis.

CORE-VNS Study Shows Sustained Seizure Reduction With VNS Therapy at 36 Months Louie Pasculli

Published Date: 29 Oct 2026

The 36-month CORE-VNS study findings showed sustained seizure reduction, improved quality of life, and reduced seizure-related hospitalizations among people with drug-resistant epilepsy receiving vagus nerve stimulation therapy.

The Expanding Role of Blood-Based Biomarkers in MS Care Louie Pasculli, Terrie Livingston, PharmD

Published Date: 29 Oct 2026

Terry Livingston, PharmD, vice president of medical affairs at Octave Bioscience, discussed the evolving role of blood-based biomarkers in multiple sclerosis care.

Matching CKD Education to Patient Readiness for Home Dialysis, With Christopher Chan, MD

Published Date: 29 Oct 2026

Matching CKD Education to Patient Readiness for Home Dialysis, With Christopher Chan, MD

Upacicalcet Lowers PTH in Secondary Hyperparathyroidism on Hemodialysis

Published Date: 29 Oct 2026

Upacicalcet Lowers PTH in Secondary Hyperparathyroidism on Hemodialysis

Tradipitant Cuts Semaglutide-Induced Vomiting in Phase 3 Trial

Published Date: 29 Oct 2026

Tradipitant Cuts Semaglutide-Induced Vomiting in Phase 3 Trial

Knowledge Hub

Oncology

Immune Dysfunction During Critical Illness in Cancer

A clinical review of immune dysfunction in critically ill patients with cancer, covering mechanisms, diagnosis, management, guidelines, and emerging therapies.

Oncology

Managing Supportive Needs During Cancer Survivorship

An evidence-based review of assessment and multidisciplinary management of physical, psychological, functional, and social needs during cancer survivorship.

Oncology

Personalized Cancer Vaccines Using Tumor Neoantigens

A medical review of personalized neoantigen cancer vaccines, including mechanisms, clinical evidence, patient selection, treatment strategies, risks, and future applications.

Oncology

AI-Based Tumor Ecosystem Mapping: Clinical Applications, Biological Mechanisms, and Translational Challenges

A medical review of AI-based tumor ecosystem mapping, including biological mechanisms, diagnostic applications, treatment implications, guideline considerations, and future clinical opportunities.

Oncology

KOL Videos

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

Your one-stop Solution for MEDICAL LEARNING & UPDATES

Phase 2 ACUITY Analysis Shows Privosegtor Associated With Smaller Early NfL and GFAP Increases in Acute Optic Neuritis Isabella Ciccone, MPH

CORE-VNS Study Shows Sustained Seizure Reduction With VNS Therapy at 36 Months Louie Pasculli

The Expanding Role of Blood-Based Biomarkers in MS Care Louie Pasculli, Terrie Livingston, PharmD

Matching CKD Education to Patient Readiness for Home Dialysis, With Christopher Chan, MD

Upacicalcet Lowers PTH in Secondary Hyperparathyroidism on Hemodialysis

Tradipitant Cuts Semaglutide-Induced Vomiting in Phase 3 Trial

Knowledge Hub

Immune Dysfunction During Critical Illness in Cancer

Managing Supportive Needs During Cancer Survivorship

Personalized Cancer Vaccines Using Tumor Neoantigens

AI-Based Tumor Ecosystem Mapping: Clinical Applications, Biological Mechanisms, and Translational Challenges

Case-Based Learning: Tumor Flare During Novel Anticancer Therapy

Age-Related Changes in Tumor Immune Cell Spatial Organization

Preventing Cancer-Associated Cachexia Through Early Muscle Proteolysis Signature Monitoring

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Page Views

Your one-stop Solution for MEDICAL LEARNING & UPDATES

Phase 2 ACUITY Analysis Shows Privosegtor Associated With Smaller Early NfL and GFAP Increases in Acute Optic Neuritis Isabella Ciccone, MPH

CORE-VNS Study Shows Sustained Seizure Reduction With VNS Therapy at 36 Months Louie Pasculli

The Expanding Role of Blood-Based Biomarkers in MS Care Louie Pasculli, Terrie Livingston, PharmD

Matching CKD Education to Patient Readiness for Home Dialysis, With Christopher Chan, MD

Upacicalcet Lowers PTH in Secondary Hyperparathyroidism on Hemodialysis

Tradipitant Cuts Semaglutide-Induced Vomiting in Phase 3 Trial

Knowledge Hub

Immune Dysfunction During Critical Illness in Cancer

Managing Supportive Needs During Cancer Survivorship

Personalized Cancer Vaccines Using Tumor Neoantigens

AI-Based Tumor Ecosystem Mapping: Clinical Applications, Biological Mechanisms, and Translational Challenges

Case-Based Learning: Tumor Flare During Novel Anticancer Therapy

Age-Related Changes in Tumor Immune Cell Spatial Organization

Preventing Cancer-Associated Cachexia Through Early Muscle Proteolysis Signature Monitoring

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Verification

Welcome to Hidoc Dr.

Page Views